{"id":2159,"date":"2018-01-18T17:10:06","date_gmt":"2018-01-18T17:10:06","guid":{"rendered":"https:\/\/www.medicalmarijuanainc.com\/?p=34197"},"modified":"2018-01-18T17:10:06","modified_gmt":"2018-01-18T17:10:06","slug":"medical-marijuana-inc-subsidiary-hempmeds-wins-product-registration-hearing-puerto-rico-begins-selling-rsho-first-ever-approved-nutraceutical-product","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2018\/01\/18\/medical-marijuana-inc-subsidiary-hempmeds-wins-product-registration-hearing-puerto-rico-begins-selling-rsho-first-ever-approved-nutraceutical-product\/","title":{"rendered":"Medical Marijuana, Inc. Subsidiary HempMeds\u00ae Wins Product Registration Hearing in Puerto Rico, Begins Selling RSHO\u2122 as First-Ever Approved Nutraceutical Product"},"content":{"rendered":"

SAN DIEGO, Jan. 18, 2018 —\u00a0Medical Marijuana, Inc.\u00a0(OTC:MJNA<\/a>), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds\u00ae had its product registrations affirmed in Puerto Rico, enabling the Company to continue selling its CBD hemp oil products,\u00a0Real Scientific Hemp Oil\u2122 (RSHO\u2122)<\/a>, freely throughout the U.S. territory. This major milestone marks another historic first for RSHO\u2122 as the first and only legally registered cannabis product to be sold in Puerto Rico as a nutritional supplement.<\/p>\n

In September of 2015, Puerto Rico’s Departmento de Salud (Department of Health) approved 12 RSHO\u2122 products through Medical Marijuana, Inc. subsidiary HempMeds\u00ae for use in the territory. In Sept. 2016, the Department of Health notified Medical Marijuana, Inc. of its intention to cancel the registration of the Company’s CBD hemp oil products, stating that “HempMeds\u00ae products contained a controlled substance (CBD) considered to be unlawful under the Classification or Schedule 1 of the Federal Law on Controlled Substances.”<\/p>\n

In July 2017, per request of Medical Marijuana, Inc. for a reconsideration of this determination, Puerto Rico’sDepartment of Health repealed its initial determination, reinstating the registration of HempMeds\u00ae products in Puerto Rico and providing the Company the right to sell them freely in the market of Puerto Rico. In appealing the decision, the Company asserted that its products were derived from the part of the plant, Cannabis Sativa L, that is exempt from the definition of “marijuana” under both the federal and Puerto Rico Controlled Substances Acts. Accordingly, the Company asserted, its products were legal under both federal and Puerto Rico law.\u00a0 The final determination held that:<\/p>\n